KCa3.1 blockers were demonstrated to decrease the spontaneous beating rate of sinoatrial node cells and reduce the arrhythmias in mice models of catecholaminergic polymorphic ventricular tachycardia 12. Here, KCNN4 is linked to cardiac arrhythmia.